American International Group, Inc. Genprex, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.11 - $4.87 $52,705 - $82,531	-16,947 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$3.66 - $7.67 $161 - $337	44 Added 0.26%	16,947 $73,000
Q4 2020 Feb 12, 2021	SELL	$3.03 - $5.51 $472 - $859	-156 Reduced 0.91%	16,903 $70,000
Q3 2020 Nov 04, 2020	SELL	$2.9 - $4.29 $1,125 - $1,664	-388 Reduced 2.22%	17,059 $57,000
Q2 2020 Aug 12, 2020	BUY	$1.99 - $3.64 $34,719 - $63,507	17,447 New	17,447 $55,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.